VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ONC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ONCBeOne Medicines Ltd.
$289.99$31.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksONCQuarterly Financials

BeOne Medicines Ltd. (ONC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

BeOne Medicines Ltd. (ONC) quarterly income statement — complete revenue, gross profit & net income history

ONC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue1.51B1.5B1.41B1.32B1.12B1.13B1B929.17M751.65M634.41M781.31M595.26M447.8M380.1M387.63M341.57M306.63M213.98M206.44M149.99M
Revenue Growth %35.46%32.84%41%41.56%48.64%77.78%28.2%56.09%67.85%66.91%101.56%74.27%46.04%77.63%87.77%127.73%-49.39%113.77%126.66%128.52%
Cost of Goods Sold167.22M142.42M196.51M164.61M165M160.56M170.46M138.13M124.94M105.83M96.31M95.99M81.79M73.52M76.54M71.17M65.24M48.55M47.41M36.26M
COGS % of Revenue11.05%9.51%13.91%12.51%14.77%14.24%17.02%14.87%16.62%16.68%12.33%16.13%18.26%19.34%19.75%20.84%21.28%22.69%22.97%24.18%
Gross Profit1.35B1.36B1.22B1.15B952.28M967.26M831.14M791.03M626.72M528.58M685M499.27M366.01M306.57M311.08M270.4M241.39M165.43M159.03M113.73M
Gross Margin %88.95%90.49%86.09%87.49%85.23%85.76%82.98%85.13%83.38%83.32%87.67%83.87%81.74%80.66%80.25%79.16%78.72%77.31%77.03%75.82%
Gross Profit Growth %41.37%40.16%46.28%45.47%51.95%82.99%21.33%58.44%71.23%72.41%120.2%84.64%51.63%85.31%95.62%137.76%-57.89%109.35%127.32%121.57%
Operating Expenses1.1B1.17B1.05B1.06B941.17M1.05B951.4M898.2M888.07M912.37M818.97M817.99M737.27M775.2M749.44M709.8M684.68M737.17M621.35M588.57M
OpEx % of Revenue72.44%78.14%74.54%80.8%84.24%92.81%94.99%96.67%118.15%143.81%104.82%137.42%164.64%203.95%193.34%207.8%223.29%344.51%300.98%392.4%
Selling, General & Admin555.1M555.29M529M537.91M459.27M504.68M455.22M443.73M427.43M416.55M365.71M395.03M328.5M328.98M322.89M331.4M294.57M306.5M269.23M232.29M
SG&A % of Revenue36.68%37.06%37.46%40.9%41.11%44.75%45.45%47.76%56.87%65.66%46.81%66.36%73.36%86.55%83.3%97.02%96.07%143.24%130.41%154.87%
Research & Development541.22M615.42M523.66M524.9M481.89M542.01M496.18M454.47M460.64M493.99M453.26M422.76M408.58M446.02M426.36M378.21M389.92M430.49M351.94M356.09M
R&D % of Revenue35.76%41.08%37.08%39.91%43.13%48.06%49.54%48.91%61.28%77.87%58.01%71.02%91.24%117.35%109.99%110.73%127.16%201.18%170.48%237.41%
Other Operating Expenses000017K00001000K0188K187K188K187K188K188K187K188K187K
Operating Income249.9M185.03M163.11M87.89M11.1M-79.42M-120.27M-107.16M-261.35M-383.8M-133.97M-318.71M-371.26M-468.62M-438.36M-439.4M-443.29M-571.74M-462.32M-474.84M
Operating Margin %16.51%12.35%11.55%6.68%0.99%-7.04%-12.01%-11.53%-34.77%-60.5%-17.15%-53.54%-82.91%-123.29%-113.09%-128.64%-144.57%-267.19%-223.95%-316.58%
Operating Income Growth %2150.96%332.97%235.63%182.01%104.25%79.31%10.23%66.38%29.6%18.1%69.44%27.47%16.25%18.04%5.18%7.46%-731.76%-17.91%-5.04%-32.31%
EBITDA291.17M395.14M179.06M123.5M43.91M-29.18M-48.97M-83.05M-236.06M-359.98M-112.46M-296.38M-351.25M-450.61M-422.16M-423.94M-426.69M-558.62M-450.15M-463.31M
EBITDA Margin %19.24%26.37%12.68%9.39%3.93%-2.59%-4.89%-8.94%-31.4%-56.74%-14.39%-49.79%-78.44%-118.55%-108.91%-124.11%-139.16%-261.06%-218.05%-308.89%
EBITDA Growth %563.16%1454.19%465.64%248.7%118.6%91.89%56.45%71.98%32.8%20.11%73.36%30.09%17.68%19.34%6.22%8.5%-634.7%-17.09%-4.25%-31.99%
D&A (Non-Cash Add-back)41.27M210.1M15.95M35.61M32.8M50.25M71.29M24.11M25.29M23.82M21.51M22.34M20.01M18.02M16.2M15.46M16.6M13.12M12.18M11.53M
EBIT249.9M207.47M147.16M87.89M11.1M-79.42M-120.27M-107.16M-261.35M-383.8M-133.97M-318.71M-371.26M-468.62M-438.36M-439.4M-443.29M-571.74M-462.32M-474.84M
Net Interest Income-5.24M12.27M3.03M3.5M5.85M7.81M10.64M13.22M16.16M16.27M26.65M15.07M16.02M18.22M12.76M11.43M10.07M-4.48M-2.23M-4.87M
Interest Income27.66M70.5M3.03M3.5M5.85M7.81M10.64M13.22M16.16M16.27M26.65M15.07M16.02M18.22M12.76M11.43M10.07M000
Interest Expense32.99M58.23M0000000000000004.48M2.23M4.87M
Other Income/Expense9.31M-35.79M-15.95M11.66M9.8M-5.93M21.96M1.24M17.92M33.02M363.31M-48.75M34.32M37.66M-112.88M-118.19M22.04M-15.06M29.25M-5.73M
Pretax Income259.21M149.24M147.16M99.55M20.9M-85.35M-98.3M-105.92M-243.43M-350.77M229.34M-367.46M-336.94M-430.96M-551.24M-557.59M-421.25M-586.8M-433.08M-480.57M
Pretax Margin %17.13%9.96%10.42%7.57%1.87%-7.57%-9.81%-11.4%-32.39%-55.29%29.35%-61.73%-75.24%-113.38%-142.21%-163.24%-137.38%-274.23%-209.78%-320.4%
Income Tax31.86M82.74M22.32M5.23M19.63M66.53M23.05M14.48M7.72M16.78M13.93M13.67M11.49M14.37M6.32M8.14M13.95M-1.15M5.04M-230K
Effective Tax Rate %12.29%55.44%15.17%5.25%93.92%-77.95%-23.44%-13.68%-3.17%-4.78%6.07%-3.72%-3.41%-3.33%-1.15%-1.46%-3.31%0.2%-1.16%0.05%
Net Income227.36M66.5M124.84M94.32M1.27M-151.88M-121.35M-120.41M-251.15M-367.55M215.41M-381.14M-348.43M-445.33M-557.56M-565.73M-435.2M-585.65M-438.11M-480.34M
Net Margin %15.02%4.44%8.84%7.17%0.11%-13.47%-12.12%-12.96%-33.41%-57.94%27.57%-64.03%-77.81%-117.16%-143.84%-165.62%-141.93%-273.7%-212.22%-320.24%
Net Income Growth %17802.13%143.79%202.88%178.34%100.51%58.68%-156.33%68.41%27.92%17.47%138.64%32.63%19.94%23.96%-27.26%-17.78%-754.48%-23.88%-3.03%-43.3%
Net Income (Continuing)227.36M66.5M124.84M94.32M1.27M-151.88M-121.35M-120.41M-251.15M-367.55M215.41M-381.14M-348.43M-445.33M-557.56M-565.73M-435.2M-585.65M-438.11M-480.34M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)25.486.7613.520.840.01-1.43-1.16-1.15-2.47-25.481.95-3.64-3.38-30.55-5.33-5.59-4.29-6.11-4.42-5.20
EPS Growth %254700%572.73%1265.52%173.04%100.4%94.39%-159.49%68.41%26.92%16.6%136.59%34.88%21.21%-400%-20.59%-7.5%-760%-17.5%8.11%-21.21%
EPS (Basic)26.657.6714.690.870.01-1.43-1.16-1.15-2.47-25.482.08-3.64-3.38-30.55-5.33-5.59-4.29-6.11-4.42-5.20
Diluted Shares Outstanding115.77M113.45M114.52M112.85M111.17M106.26M104.7M104.7M104.27M104.08M106.95M104.63M104.17M103.76M103.48M102.8M102.46M95.03M92.77M91.85M
Basic Shares Outstanding110.96M109.06M110.22M108.57M106.93M106.26M104.7M104.7M104.27M104.08M104.67M104.63M104.17M103.76M103.48M102.8M102.46M95.03M92.77M91.85M
Dividend Payout Ratio--------------------